BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 8, 2003
View Archived Issues
Sequential combination therapy reported effective in advanced follicular lymphoma
Read More
Motexafin lutetium phototherapy in coronary artery disease
Read More
Improved erectile dysfunction reported with moxonidine in hypertensive men
Read More
Antitumor efficacy and safety of arzoxifene in advanced endometrial cancer
Read More
Successful conversion of PSVT to sinus rhythm reported with tecadenoson
Read More
No adverse effects found with adalimumab on skin response to UVB irradiation
Read More
Sanofi-Synthelabo and Mitsubishi Pharma present new GSK-3beta inhibitors
Read More
New ICE/ced-3 inhibitors reported by Idun researchers
Read More
Basilea patent describes new ketolide antibiotics
Read More
Boehringer Ingelheim claims novel cytokine production inhibitors and their use
Read More
Novel glucocorticoid agonists developed by GSK researchers
Read More
Scientists at Pfizer discover new beta3-adrenoceptor agonists
Read More
New beta2-adrenoceptor agonists for use in respiratory disorders patented by GSK
Read More
SBIR grant for development of stem cell treatment for diabetic circulation ischemia
Read More
Orphan drug status for OGP(10-14)L for chronic idiopathic myelofibrosis
Read More
Acorda expands fampridine licensing rights
Read More
Resubmitted NDA for Helicide deemed not approvable
Read More
Biota signs influenza drug collaboration and license agreement with Sankyo
Read More
S.O.A.R. collaboration to evaluate KRX-101 for focal segmental glomerulosclerosis
Read More
Phase IIa trial confirms glucose-lowering ability of CS-917 in diabetics
Read More
NeuTec seeks development partners for Mycograb for cancer
Read More
Approvable letter issued for Enablex for overactive bladder
Read More
Savient and Teva in preliminary acquisition discussions
Read More
Favorable recommendation for Luveris in follicular development
Read More
CHF-4227: profile of a new SERM for osteoporosis
Read More
Optimer heading for clinical evaluation with new C. difficile-selective antibiotic
Read More
Bone anabolic effects of Apomine in mice
Read More